Delivery Order SPE2DR25D9130-SPE2DR26FCEY5
- Not listed
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $16,701.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents one of numerous recent awards issued to DMS...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $36,196.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. This firm fixed-price delivery order was issued on October 24, 2025, with an ultimate completion date of October 27, 2025, and carries no set-aside designation, indicating the award was made through...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc. on October 23, 2025, for YF-VAX (yellow fever vaccine) in one-dose vials to be delivered to Park Ridge, Illinois, with completion by November 14, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price delivery order with no set-aside designation. The award reflects the company's...
- The Defense Logistics Agency awarded a $1,113.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) in single-dose vials on October 20, 2025. The delivery order, with an ultimate completion date of November 10, 2025, carries no set-aside designation, allowing the woman-owned small business to compete directly against other qualified vendors. DMS Pharmaceutical Group, headquartered in Park Ridge, Illinois, is the sole awardee with no identified...
- The Defense Logistics Agency awarded a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The contract utilizes firm fixed-price pricing with an ultimate completion date of November 13, 2025, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- On August 19, 2025, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order calls for the supply of YF-VAX 1 Dose Vials, a yellow fever vaccine, with an ultimate completion date of September 10, 2025. This award was issued without a set-aside designation, demonstrating the contractor's competitive position in the...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $1,113.42 for YF-VAX 1 dose vials. Issued on September 2, 2025, with completion expected by September 23, 2025, this firm fixed-price delivery order represents a discrete purchase under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The award carries no set-aside designation, allowing the...
- The Defense Logistics Agency awarded a $1,113.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 Dose Vials. The contract, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency awarded a delivery order valued at $11,134.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract, issued on August 13, 2025, with an ultimate completion date of September 4, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite...
- SPE2DR25D9130Indefinite Delivery Contract
- SPE2DR25D9130-SPE2DR26FCEY5Delivery Order
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. The award, issued on October 20, 2025, carries a ceiling value of $5,567.60 under a firm fixed-price delivery order structure with an ultimate completion date of November 10, 2025. This delivery order was issued without set-aside designation, reflecting the contractor's demonstrated competitive capability in unrestricted federal pharmaceutical procurement. The work will be performed at the contractor's Park Ridge, Illinois facility. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to establish regional prime vendor contractors for pharmaceutical supply to Department of Defense healthcare facilities worldwide. The parent contract, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for comprehensive pharmaceutical products including vaccines, prescription medications, biologics, and medical consumables to support military medical operations globally. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability as a critical supplier within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 10/20/25 |